Diametric Capital, LP Edwards Lifesciences Corp Transaction History

Diametric Capital, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $33,586 - $44,244	-463 Reduced 8.78%	4,811 $459,000
Q4 2023 Feb 13, 2024	BUY	$61.71 - $77.76 $325,458 - $410,106	5,274 New	5,274 $402,000
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $543,655 - $629,935	-6,678 Reduced 64.92%	3,609 $340,000
Q1 2023 May 11, 2023	BUY	$74.26 - $84.51 $763,912 - $869,354	10,287 New	10,287 $851,000
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $816,300 - $1.21 Million	9,437 New	9,437 $897,000
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $615,313 - $711,021	-11,039 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $528,657 - $707,047	11,039 New	11,039 $2.11 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $340,602 - $417,882	-7,339 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $335,392 - $425,882	7,339 New	7,339 $1.28 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.